Related Experiment Video

Updated: Apr 18, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

796

Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case-control

Alexander Michel1, Mar Martín-Pérez, Ana Ruigómez

  • 1Bayer Pharma AG, Global Epidemiology, Berlin, Germany.

European Journal of Heart Failure
|January 13, 2015
PubMed

Insights

Patients with heart failure face increased hyperkalaemia risk due to renal failure, diabetes, and certain medications like potassium-sparing diuretics and ACE inhibitors. Monitoring is crucial, especially when starting new treatments.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Heart failure is a significant cardiovascular condition.
  • Hyperkalaemia (high potassium levels) is a serious complication.
  • Identifying risk factors is crucial for patient management.

Purpose of the Study:

  • To identify risk factors for hyperkalaemia in newly diagnosed heart failure patients in the UK.
  • To inform clinical monitoring strategies for this vulnerable population.

Main Methods:

  • Nested case-control study using The Health Improvement Network primary care database.
  • Cohort of 19,194 patients with newly diagnosed heart failure (2000-2005).
  • Unconditional logistic regression to calculate odds ratios for risk factors.

Main Results:

  • 2,176 hyperkalaemia cases identified over a mean follow-up of 3.9 years.
  • Significant risk factors included renal failure, type II diabetes, valvular heart disease.
  • Medications associated with increased risk: potassium-sparing diuretics, ACE inhibitors, trimethoprim, NSAIDs.

Conclusions:

  • Findings aid in identifying heart failure patients needing close serum potassium monitoring.
  • Vigilance is particularly important during the initial phase of certain medication treatments.
Abstract

Keywords:
Case-controlHeart failureHyperkalaemiaRisk factors

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
631
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
765
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K